BlackRock and JPMorgan Chase are two of the most closely watched succession sagas on Wall Street. With full-year earnings ...

Hopkins is a New York-based reporter for The Wall Street Journal, where he covers healthcare ... He writes frequently on drug development and pricing, deals and the Covid-19 pandemic.

While outward shifts of the demand curve would be welcome, China's leadership appears loathe to pursue that with policy tools ...

Soma Biswas covers restructuring and bankruptcy for The Wall Street Journal and WSJ Pro ... and organizations that turned to bankruptcy to deal with a flood of personal injury lawsuits over ...

Discover three top monthly dividend stocks offering stability, growth potential, and consistent payouts for income investors ...

Save 25% on Revo’s Performance-Driven Sunglasses ...

How are South Florida companies bracing for potential tariffs on China? Lennar's co-CEO and the regional president of the ...

Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

Anthropic may be joining rival OpenAI with its own eye-popping valuation, but the hefty valuations for the two biggest AI startups obscure the fact that, for now, these companies are burning through ...

The nation’s second-largest carrier is playing catch-up to rivals after its bet to overhaul corporate travel failed.

Albertsons is the third-largest grocery chain in the U.S., preceded by Kroger at number two and Walmart at number one.

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...